(Q35103061)

6 August 2017

1 reference

title

Venous thromboembolism prophylaxis in the medically ill patient (English)

1 reference

6 August 2017

main subject

venous thromboembolism

1 reference

Franklin A Michota

1

1 reference

6 August 2017

publication date

1 March 2003

1 reference

6 August 2017

number of pages

9

1 reference

Clinics in Chest Medicine

inferred from page(s)

published in

1 reference

6 August 2017

volume

24

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

93-101

1 reference

Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

Cost of Long-Term Complications of Deep Venous Thrombosis of the Lower Extremities: An Analysis of a Defined Patient Population in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

Prevention of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

New onset of venous thromboembolism among hospitalized patients at Brigham and Women's Hospital is caused more often by prophylaxis failure than by withholding treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

The prothrombin 20210 G to A variation and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

Epidemiology of venous thromboembolic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

The prevalence of risk factors for venous thromboembolism among hospital patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

Graduated compression stockings in the prevention of deep vein thrombosis in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

Pneumatic sequential compression reduces the risk of deep vein thrombosis in stroke patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

The incidence of deep venous thrombosis in ICU patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

Delirium: a symptom of how hospital care is failing older persons and a window to improve quality of hospital care

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

Prevention of deep vein thrombosis in medical patients by low-dose heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

High risk of the critically ill for venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

Reduction of mortality in general medical in-patients by low-dose heparin prophylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

Economic evaluation of the MEDENOX trial: a Canadian perspective. Medical Patients with Enoxaparin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900078-3

7 January 2021

10.1016/S0272-5231(02)00078-3

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/72bkpwu4ezhq3ae7jlqquiwtvy

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_72bkpwu4ezhq3ae7jlqquiwtvy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/72bkpwu4ezhq3ae7jlqquiwtvy

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/72bkpwu4ezhq3ae7jlqquiwtvy

1 reference

30 July 2022